|
|
||||||||
Viewpoint |
1 From the Department of Medicine, Weill Medical College of Cornell University, New York, NY, the Department of Epidemiology and Biostatistics, and the Department of Medicine, McGill University, Montreal, Quebec, Canada (O.S.M.); and the Department of Radiology, New York Presbyterian Hospital-Weill Cornell Medical Center, 525 E 68th St, New York, NY 10021 (C.I.H.). Received October 12, 2000; revision requested October 24; revision received December 29; accepted January 17, 2001. Address correspondence to C.I.H. (e-mail: chensch@med.cornell.edu).
The practicing radiologist today is well persuaded that earlier diagnosis of lung cancer can be achieved with traditional-type radiography and especially with modern computed tomography. The practitioner also is confident that intervention in the context of earlier diagnosis is more effective in preventing death due to this otherwise fatal disease. The practitioner is thus inclined to consider such screening in a high-risk person with suitably long life expectancy, especially when asked to provide it. On the other hand, the practitioner is aware of official recommendations against lung cancer screening, said to be based on demonstrated lack of effectiveness of traditional radiographic screening. Some researchers have expressed concerns about screening-associated "overdiagnosis." Given this dilemma, the critically thinking practitioner is concerned to understand the foundation of the official nihilism in evidence and reasoning, as she or he suspects that something may be seriously wrong in this. This article is an attempt to help such a practitioner in this effortan effort that in the end is rewarded by the comforting realization that the nihilistic recommendations and hesitation-provoking cautions are founded on pseudoevidence and specious reasoning.
Index terms: Computed tomography (CT), utilization Lung neoplasms, CT, 60.12111 Lung neoplasms, diagnosis, 60.32 Lung neoplasms, screening Lung neoplasms, staging
This article has been cited by other articles:
![]() |
J M Reich A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening Thorax, April 1, 2008; 63(4): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Black, D. R. Aberle, C. D. Berg, and For the Executive Committee of the National Lung S Large Field Trial for Lung Cancer Screening: Putting the Wrong Cart before the Horse? Radiology, May 1, 2007; 243(2): 314 - 316. [Full Text] [PDF] |
||||
![]() |
C. T. Kolber, G. Zipp, D. Glendinning, and J. J. Mitchell Patient Expectations of Full-Body CT Screening Am. J. Roentgenol., March 1, 2007; 188(3): W297 - W304. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gordon, L. A. Deters, M. D. Nitz, B. C. Lieberman, B. Y. Yeap, and R. Bueno Differential diagnosis of solitary lung nodules with gene expression ratios J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Obuchowski and M. T. Modic Screening with Multisection CT: Unmasking the Benefit Radiology, November 1, 2005; 237(2): 401 - 403. [Full Text] [PDF] |
||||
![]() |
G. S. Gazelle, P. M. McMahon, U. Siebert, and M. T. Beinfeld Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies Radiology, May 1, 2005; 235(2): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bianchi, J. Hu, G. Pelosi, R. Cirincione, M. Ferguson, C. Ratcliffe, P. P. Di Fiore, K. Gatter, F. Pezzella, and U. Pastorino Lung Cancers Detected by Screening with Spiral Computed Tomography Have a Malignant Phenotype when Analyzed by cDNA Microarray Clin. Cancer Res., September 15, 2004; 10(18): 6023 - 6028. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brenner Radiation Risks Potentially Associated with Low-Dose CT Screening of Adult Smokers for Lung Cancer Radiology, May 1, 2004; 231(2): 440 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.I. Henschke, D.F. Yankelevitz, D.I. McCauley, D.M. Libby, M.W. Pasmantier, and J.P. Smith Guidelines for the use of spiral computed tomography in screening for lung cancer Eur. Respir. J., January 1, 2003; 21(39_suppl): 45S - 51s. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Shah, J. H. M. Austin, C. S. White, P. Patel, L. B. Haramati, G. D. N. Pearson, M. C. Shiau, and Y. M. Berkmen Missed Non-Small Cell Lung Cancer: Radiographic Findings of Potentially Resectable Lesions Evident Only in Retrospect Radiology, January 1, 2003; 226(1): 235 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Armato III, F. Li, M. L. Giger, H. MacMahon, S. Sone, and K. Doi Lung Cancer: Performance of Automated Lung Nodule Detection Applied to Cancers Missed in a CT Screening Program Radiology, December 1, 2002; 225(3): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vermont Lung Cancer Screening: Necessary Cartesian Doubtfulness Is Not Nihilism Radiology, December 1, 2002; 225(3): 920 - 920. [Full Text] [PDF] |
||||
![]() |
W. J. Casarella A Patient's Viewpoint on a Current Controversy Radiology, September 1, 2002; 224(3): 927 - 927. [Full Text] [PDF] |
||||
![]() |
F. M. Hall, E. F. Patz Jr, W. C. Black, and P. C. Goodman Screening for Lung Cancer: Been There and Done That * Dr Patz and colleagues respond: Radiology, September 1, 2002; 224(3): 928 - 929. [Full Text] [PDF] |
||||
![]() |
E. F. Patz Jr, W. C. Black, and P. C. Goodman Commentary on Drs Miettinen and Henschke's Viewpoint Radiology, December 1, 2001; 221(3): 597 - 597. [Full Text] [PDF] |
||||
![]() |
O. S. Miettinen and C. I. Henschke Commentary on Drs Patz, Black, and Goodman's Viewpoint Radiology, December 1, 2001; 221(3): 598 - 599. [Full Text] [PDF] |
||||